Finance

Lists
301047:SHE
Sino Biological Inc
CNÂ¥97.63
-4.20%
(-4.28) 1D
Aug 31, 2:24:43 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301047...
Open
CNÂ¥98.00
High
CNÂ¥99.76
Low
CNÂ¥96.00
Mkt. cap
12.40B
Avg. vol.
8.98M
Volume
5.88M
Dividend
5.33%
Quarterly dividend
CNÂ¥1.30
Ex-dividend date
May 15, 2026
P/E ratio
71.86
52-wk high
CNÂ¥139.49
52-wk low
CNÂ¥58.05
EPS
CNÂ¥1.36
Shares outstanding
121.64M
No. of employees
1K
Open
CNÂ¥98.00
High
CNÂ¥99.76
Low
CNÂ¥96.00
Mkt. cap
12.40B
Avg. vol.
8.98M
Volume
5.88M
Dividend
5.33%
Quarterly dividend
CNÂ¥1.30
Ex-dividend date
May 15, 2026
P/E ratio
71.86
52-wk high
CNÂ¥139.49
52-wk low
CNÂ¥58.05
EPS
CNÂ¥1.36
Shares outstanding
121.64M
No. of employees
1K
About Sino Biological Inc
CEO-
Employees1.07K
FoundedDec 22, 2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
186.99M
188.12M
183.42M
209.47M
Cost of goods sold
46.31M
57.23M
45.01M
53.50M
Cost of revenue
46.31M
57.23M
45.01M
53.50M
Research and development expenses
24.00M
19.70M
22.96M
19.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.28M
83.31M
82.09M
87.62M
Operating expense
100.83M
113.44M
106.36M
110.24M
Total operating expenses
147.14M
170.68M
151.37M
163.74M
Operating income
39.85M
17.44M
32.06M
45.73M
Other non operating income
-2.40M
2.32M
-6.12M
-10.44M
EBT including unusual items
47.92M
55.07M
44.16M
58.77M
EBT excluding unusual items
42.22M
26.79M
38.47M
47.22M
Income tax expense
5.42M
17.51M
12.01M
5.73M
Effective tax rate
11.32%
31.80%
27.20%
9.75%
Other operating expenses
1.29M
5.76M
-230.14K
4.34M
Net income
42.49M
37.56M
32.15M
53.05M
Net profit margin
22.72%
19.96%
17.53%
25.32%
Earnings per share
-
-
-
-
Interest and investment income
6.38M
11.12M
13.23M
11.94M
Interest expense
-763.51K
-661.42K
-701.66K
-
Net interest expenses
5.62M
10.46M
12.53M
11.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
56.10M
33.73M
48.34M
61.00M
Gain or loss from assets sale
-42.58K
-537.38K
-
428.15K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps